Efficacy and Safety of Minidosing Lysergic Acid Diethylamide (LSD) for Chronic Cluster Headache: a Randomized Placebo-controlled Study

Phase: PHASE2 | Sponsor: Radboud University Medical Center | Compound: LSD

Status

recruiting

Institution

Radboud University Medical Center

Start date

2025-04-16

End date

2027-04-01

Registry ID

NCT05477459

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.